WO2020252277A1 - Making delta 8 thc, delta 10 thc and/or cannabinol from cbd - Google Patents
Making delta 8 thc, delta 10 thc and/or cannabinol from cbd Download PDFInfo
- Publication number
- WO2020252277A1 WO2020252277A1 PCT/US2020/037456 US2020037456W WO2020252277A1 WO 2020252277 A1 WO2020252277 A1 WO 2020252277A1 US 2020037456 W US2020037456 W US 2020037456W WO 2020252277 A1 WO2020252277 A1 WO 2020252277A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- thc
- cbd
- extract
- isolate
- homolog
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H5/00—Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
- A01H5/02—Flowers
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H5/00—Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
- A01H5/12—Leaves
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H6/00—Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
- A01H6/28—Cannabaceae, e.g. cannabis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
Definitions
- the present application relates to methods of making of delta 8 tetrahydrocannabinol ( D 8 THC), delta 10 tetrahydrocannabinol ( D 10 THC) and/or cannabinol (CBN) with or without using a solvent.
- D 8 THC delta 8 tetrahydrocannabinol
- D 10 THC delta 10 tetrahydrocannabinol
- CBN cannabinol
- Delta-8-THC is an analog of tetrahydrocannabinol (THC) with antiemetic, anxiolytic, appetite-stimulating, analgesic, and neuroprotective properties.
- D 8 THC binds to the cannabinoid G-protein coupled receptor CB1, located in the central nervous system. This agent exhibits a lower psychotropic potency than Delta-9-THC (D 9 THC), the primary form of THC found in cannabis.
- D 8 THC is chemically different fromD 9 THC by only a few atomic bonds. While D 8 THC only exists naturally in fractions of a percent, it may be used in a variety of applications, offering unique effects.
- D 10 THC is a derivative and isomer of CBD and D 9 THC.
- Cannabinol (CBN) is a mildly psychoactive cannabinoid found only in trace amounts in Cannabis, mostly in aged Cannabis.
- Some embodiments relate to a method of making delta 8 tetrahydrocannabinol (D 8 THC), delta 10 tetrahydrocannabinol (D 10 THC) and/or cannabinol (CBN), the method including: a) providing an extract or composition that comprises at least one of delta 9 tetrahydrocannabinol (D9 THC) or a cannabidiol (CBD);
- the extract or composition includes CBD.
- the CBD is converted to D 8 THC.
- At least 50% of the CBD is converted to D 8 THC.
- At least 99% of the CBD is converted to D 8 THC.
- At least 90% of the CBD is converted to D 8 THC.
- substantially all CBD is converted to D 8 THC.
- the extract or composition is heated to at least 55 degrees centigrade.
- At least 1.0 g of iodine is employed.
- a ratio of 0.001:1 w/w of iodine to CBD is used.
- the method further includes the addition of calcium carbonate to the heated extract or composition.
- the method further includes the addition of sodium thiosulphate.
- the extract or composition is prepared by CO 2 extraction. [0019] In some examples, a ratio of 40 g of extract or composition is employed to 1.2g of elemental iodine.
- the extract or composition is first heated to at least 55 degrees centigrade for 20 minutes while stirring and then heated to at least 55 centigrade for at least 20 minutes.
- the extract or composition is first heated to 90 degrees centigrade.
- the method includes stirring and heating to at least 100 degrees centigrade.
- the process does not include the addition of a solvent.
- the process does not involve a use of a solvent between providing a extract or composition and production of D 8 THC.
- no organic solvent is employed during a heating step b).
- no organic solvent is employed during a, b, c, or d.
- no organic solvent is employed during the process.
- the extract or composition is CO 2 extracted from hemp.
- the extract or composition is decarboxylated.
- the extract or composition is CO 2 extracted from hemp and the extract or composition is then decarboxlated in order to produce the extract or composition used as the starting material.
- Some embodiments relate to a method of making D 8 THC, the method including:
- the catalyst is a metallic catalyst.
- the catalyst is a non-metallic catalyst.
- the extract is a plant extract.
- Some embodiments relate to a method of making D 8 THC and/or CBN (and/or homologs thereof), the method including:
- CBD CBD (or a homolog thereof) is converted into D8 THC and/or CBN (Cannabinol) (or a homolog thereof).
- the CBD homolog is cannabidivarin (CBDV).
- the reaction produces at least Tetrahydrocannabivarin (THCV).
- the isolate comprises between 20-95% CBD (or CBDV).
- the CBD is converted to D 8 THC.
- the halogen or a free radical generator includes iodine.
- any of the embodiments provided herein regarding a halogen or free radical generator can employ a halogen containing molecule.
- At least 50% of the CBD is converted to D 8 THC.
- at least 99% of the CBD is converted to D 8 THC.
- At least 90% of the CBD is converted to D 8 THC.
- substantially all CBD is converted to D 8 THC and CBN.
- substantially all CBDV is converted to D 8 THCV and CBV.
- CBDV is converted to D 8 THCV and CBV.
- the isolate is heated to at least 70 degrees centigrade.
- At least 1.0 g of iodine is employed.
- At least ratio of 0.001:1 w/w of iodine to CBD (or CBDV) isolate is used.
- iodine to CBD (or CBD) isolate is used.
- the CBD isolate (or CBDV isolate) is between 20 and 99% CBD and comprises at least one of propane or butane.
- the reaction is carried out between 1 torr and 3 million torr.
- the method further includes the addition of sodium thiosulphate as a quencher.
- the isolate is prepared by CO 2 extraction.
- the isolate is first heated to at least 55 degrees centigrade for 20 minutes while stirring and then heated to at least 55 centigrade for at least 20 minutes.
- the isolate is first heated to 90 degrees centigrade.
- the process does not comprise the addition of a solvent.
- the process is performed in a solvent.
- the isolate is decarboxylated.
- Some embodiments relate to a method of making D 8 THC and/or CBN or a homolog thereof, the method comprising:
- CBD or homolog thereof is converted into D8 THC (or a homolog thereof) and/or CBN (or a homolog thereof).
- the isolate is from a plant.
- FIG. 1 depicts some embodiments of a reaction scheme in which a“CBD homolog” (formula A) is converted to a“THC homolog” (including, for example, THCV) as in formula C and/or a“CBN homolog” (including, for example, CBV) as in formula D.
- a“CBD homolog” formula A
- a“THC homolog” including, for example, THCV
- a“CBN homolog” including, for example, CBV
- D 8 THC, D 10 THC and/or CBN are provided herein.
- Some embodiments relate to using D 9 THC or a CBD (cannabidiol) as a starting agent in the production of D 8 THC, D 10 THC and/or CBN via a solvent-less method.
- the methods involve heat and/or iodine (or any halogen or free radical generator as an alternative to iodine).
- the method is applied to an isolate, which can include, for example, a hemp isolate.
- the method is applied to any isolate, that has been isolated from, for example, hemp.
- the hemp isolate contains between 95 and 20% CBD in terms of purity.
- the isolate can also contain pentane and/or butane.
- the reaction starts with CBD and produces D 8 THC and/or CBN.
- the method can be applied to homologs thereof.
- the reaction starts with CBDV to convert it to D 9 THCV and then onto D 8 THCV and CBV (cannabidivarin). Any of the embodiments (including those in the claims) provided herein with respect to one of these embodiments can be applied to the homolog embodiments as well.
- the reaction to produce D 8 THC and/cannabinol from CBD can be quenched with sodium thiosulfate.
- the method involves an isolate of greater than 95% purity of CBD that can be converted into D 8 THC and CBN with (and optionally solely) using iodine (or other options provided herein) and heat.
- the reaction comprises or consists of that outlined below (and in FIG.1):
- R1 and R2 can be any alkyl group.
- R1 and R2 are separately selected from any alkyl that is 1-20 carbon atoms in length.
- the term“alkyl,” alone or in combination, refers to a fully saturated aliphatic. In certain embodiments, alkyls are optionally substituted.
- an alkyl comprises 1 to 20 carbon atoms (whenever it appears herein, a numerical range, such as“1 to 20” or“C 1 -C 20 ”, refers to each integer in the given range; e.g.,“C 1 -C 20 alkyl” means that an alkyl group comprising only 1 carbon atom, 2 carbon atoms, 3 carbon atoms, etc., up to and including 20 carbon atoms).
- alkyls include, but are not limited to, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, tert-amyl, pentyl, hexyl, heptyl, octyl and the like.
- any of the compounds provided with respect to the options of R1 and R2 in the reaction diagram above can be applied in the context of any one of more of the embodiments and claims recited herein (simply by inserting the particular starting formula and following the reaction through, in place of the CBD embodiments provided in the claims below.
- the term“CBD homolog” denotes those options encompassed within formula A above.
- the term“THC homolog” (such as THCV) denotes those options encompassed within formula C above.
- CBN homolog (such as CBV) denotes those options encompassed within formula D above.
- R1 is 5 and R2 is one carbon.
- the method in FIG.1 further comprises:
- the reaction comprises or consists of that outlined below:
- CBD or homologs thereof denotes both the general class of CBD:
- CBDV cannabidivarin
- Cannabinol denotes a compound with the following structure:
- the reaction is a generalized reaction in the presence of iodine, or another halogen, or a free radical generating species.
- the reaction is one as outlined in FIG.1.
- the reaction is a method to convert a CBD homolog to one or both of a CBN homolog and/or a THC homolog, for example, as shown in FIG.1.
- the reaction is carried out under atmospheric pressure. In some embodiments, the reaction is carried out between 1 torr and 3 million torr. In some embodiments, prior to adding the quencher, the reaction is allowed to continue for at least 30 minutes, for example, 0.5, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 24 hours or more, including 1, 2, 3, 4, 5, 6, 7 or more days, include 1, 2, or 3 or more months. In some embodiments, the reaction is one as outlined in FIG.1. In some embodiments, the reaction is a method to convert a CBD homolog to one or both of a CBN homolog and/or a THC homolog, for example, as shown in FIG.1.
- the reaction is carried out under neutral or acidic conditions. In some embodiments, the reaction is one as outlined in FIG.1. In some embodiments, the reaction is a method to convert a CBD homolog to one or both of a CBN homolog and/or a THC homolog, for example, as shown in FIG.1.
- this is a one-pot process.
- the reaction is one as outlined in FIG. 1.
- the reaction is a method to convert a CBD homolog to one or both of a CBN homolog and/or a THC homolog, for example, as shown in FIG.1.
- the oxane (tetrahydropyran) ring closure occurs (CBD to D9 THC) followed by an isomerization of the double bond around the 9 th carbon (THC carbon numbering shown below).
- this produces a more potent local analgesic isomer from CBD, delta 8 THC when topically applied reduces inflammation and pain.
- CBDV is used as a starting compound (as a CBD homolog)
- the reaction produces an isomer (THCV) that increases sensitivity to insulin as well as functions as an appetite suppressant in higher doses.
- a method of making delta 8 tetrahydrocannabinol ( D 8 THC) is provided.
- the method comprises:
- D 9 THC delta 9 tetrahydrocannabinol
- CBD cannabidiol
- a-d can be applied to the homolog reaction process shown in FIG.1.
- the extract or composition is heated to 70°C, 71°C, 72°C, 73°C, 74°C, 75°C, 76°C, 77°C, 78°C, 79°C, 80°C, 81°C, 82°C, 83°C, 84°C, 85°C, 86°C, 87°C, 88°C, 89°C, 90°C, 91°C, 92°C, 93°C, 94°C, 95°C, 96°C, 97°C, 98°C, 99°C, 100°C, 101°C, 102°C, 103°C, 104°C, 105°C, 106°C, 107°C, 108°C, 109°C, 110°C, 115°C, 120°C, 125°C, 130°C, 135°C, 140°C, 145°C, 150°C, 155°C, 160°C,
- the reaction is one as outlined in FIG. 1. In some embodiments, the reaction is a method to convert a CBD homolog to one or both of a CBN homolog and/or a THC homolog, for example, as shown in FIG.1.
- the w/w ratio of iodine to CBD to the heated extract or composition is 0.0005:1, 0.0010:1, 0.0015:1, 0.0020:1, 0.0025:1, 0.0030:1, 0.0035:1, 0.0040:1, 0.0045:1, 0.0050:1, 0.0055:1, 0.0060:1, 0.0065:1, 0.0070:1, 0.0075:1, 0.0080:1, 0.0085:1, 0.0090:1, 0.0095:1, 0.0100:1, 0.0150:1, 0.0200:1, 0.0250:1, 0.0300:1.
- the reaction is one as outlined in FIG.1.
- the reaction is a method to convert a CBD homolog to one or both of a CBN homolog and/or a THC homolog, for example, as shown in FIG.1.
- step (d) the heating is continued for 20 min., 25 min., 30 min., 35 min., 40 min., 45 min., 50 min., 55 min., 1 hr., 1.5 hr, 2 hr., 2.5 hr, 3 hr., 3.5 hr, 4 hr., 4.5 hr., 5 hr., 5.5 hr, 6 hr., 6.5 hr, 7 hr., 7.5 hr, 8 hr., 8.5 hr, 9 hr., 9.5 hr,10 hr, 12 hr, 13hr, 14 hr, 15 hr, 16 hr, 17 hr, 18 hr, 19 hr, 20 hr, 21 hr, 22 hr, 23 hr, 24 hr, 48 hr or 72 hr, including any range defined between any two of the preceding values.
- the reaction is one as outlined in FIG.1. In some embodiments, the reaction is a method to convert a CBD homolog to one or both of a CBN homolog and/or a THC homolog, for example, as shown in FIG.1.
- the extract or composition comprises CBD.
- the CBD is converted to D 8 THC.
- the amount of CBD converted to D 8 THC is 1%, 2%, 5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99%, 99.9%, 99.99%, 99.999%, or greater.
- the reaction is one as outlined in FIG.1.
- the reaction is a method to convert a CBD homolog to one or both of a CBN homolog and/or a THC homolog, for example, as shown in FIG.1.
- At least 50% of the CBD is converted to D 8 THC.
- At least 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90% 95%, 96% 97%, 98%, 99%, 99.9%, 99.99%, 99.999%, or greater of the CBD is converted to D 8 THC.
- at least 99% of the CBD is converted to D 8 THC.
- at least 90% of the CBD is converted to D 8 THC.
- substantially all CBD is converted to D 8 THC.
- the extract or composition is heated to at least 55 degrees centigrade.
- the extract or composition is heated to 55°C, 56°C, 57°C, 58°C, 59°C, 60°C, 61°C, 62°C, 63°C, 64°C, 65°C, 66°C, 67°C, 68°C, 69°C, 70°C, 71°C, 72°C, 73°C, 74°C, 75°C, 76°C, 77°C, 78°C, 79°C, 80°C, 81°C, 82°C, 83°C, 84°C, 85°C, 86°C, 87°C, 88°C, 89°C, 90°C, 91°C, 92°C, 93°C, 94°C, 95°C, 96°C, 97°C, 98°C, 99°C, 100°C, 101°C, 102°C, 103°C, 104°C, 105°C,
- At least 1.0 g of iodine is employed. In some examples, at least 0.1 g, 0.2 g, 0.3 g, 0.4 g, 0.5 g, 0.6 g, 0.7 g, 0.8 g, 0.9 g, 1.0 g. 1.5 g, 2.0 g, 2.5 g, 3.0 g, 3.5 g, 4.0 g, 4.5 g, 5.0 g or 10 g of iodine is employed. [0103] In some examples, a ratio of 0.001:1 w/w of iodine to CBD is used.
- the w/w ratio of iodine to CBD to the heated extract or composition is 0.0001:1, 0.0005:1, 0.0010:1, 0.0015:1, 0.0020:1, 0.0025:1, 0.0030:1, 0.0035:1, 0.0040:1, 0.0045:1, 0.0050:1, 0.0055:1, 0.0060:1, 0.0065:1, 0.0070:1, 0.0075:1, 0.0080:1, 0.0085:1, 0.0090:1, 0.0095:1, 0.0100:1, 0.0150:1, 0.0200:1, 0.0250:1, 0.0300:1, 0.0500:1, 0.1000:1, 0.5000:1, 1:1, 2:1, 3:1, 4:1, 5:1, 6:1, 7:1, 8:1, 9:1 or 10:1.
- the method further comprises the addition of calcium carbonate to the heated extract or composition.
- method further comprises the addition of sodium thiosulphate.
- the extract or composition is prepared by CO 2 extraction.
- Cannabis oil is usually extracted on a commercial scale either through the use of solvents such as hexane or butane, or through more modern supercritical/subcritical CO 2 (carbon dioxide) processes.
- Carbon dioxide-based extraction is considered to be more environmentally friendly, considerably safer, cleaner, cheaper and less toxic than using fossil fuel-based extraction, and results in a consistent product that is more palatable.
- carbon dioxide is a gas. At 60.4 psi it is a liquid and at -78°C, at standard pressure, it is a solid (dry ice).
- Supercritical liquids can pass through porous solids and also dissolve materials, making them ideal as a solvent.
- The“tunability” of supercritical CO 2 extraction enables targeting maximum outputs of cannabidiol depending on the type and quality of cannabis material being used; while keeping undesirable compounds such as chlorophyll out of the product.
- a pump forces pressurized carbon dioxide gas at the optimum supercritical temperature (ScCO 2 ) into the extractor chamber.
- the supercritical carbon dioxide interacts with the cannabis, dissolving the cannabinoid compounds it contains.
- the supercritical CO 2 carries the cannabis oil particles past a pressure release valve to a cyclonic separator.
- the pressure is lower and the carbon dioxide and cannabis oil separates.
- the cannabis oil, waxes and resins descend in the separator where they are captured by a collection vessel.
- the resulting substance is processed further into various products, such as CBD-rich“cannabis oil”, free of any solvents.
- a ratio of 40 g of extract or composition is employed to 1.2g of elemental iodine (i.e., a 33.33:1 ratio of extract/composition to elemental iodine).
- the ratio of extract/composition to elemental iodine is 5:1, 10:1, 15:1, 20:1, 25:1, 30:1, 35:1, 40:1, 45:1, 50:1, 55:1, 60:1, 65:1, 70:1, 75:1, 80:1, 85:1, 90:1, 95:1 or 100:1.
- the extract or composition is first heated to at least 55 degrees centigrade for 20 minutes while stirring and then heated to at least 55 centigrade for at least 20 minutes.
- the extract or composition is heated to 55°C, 56°C, 57°C, 58°C, 59°C, 60°C, 61°C, 62°C, 63°C, 64°C, 65°C, 66°C, 67°C, 68°C, 69°C, 70°C, 71°C, 72°C, 73°C, 74°C, 75°C, 76°C, 77°C, 78°C, 79°C, 80°C, 81°C, 82°C, 83°C, 84°C, 85°C, 86°C, 87°C, 88°C, 89°C, 90°C, 91°C, 92°C, 93°C, 94°C, 95°C, 96°C, 97°C, 98°C, 99°C, 100°C, 101°C, 102°C, 103°C, 104°C, 105°C, 100°C, 101°C
- the heating is continued for 20 min., 25 min., 30 min., 35 min., 40 min., 45 min., 50 min., 55 min., 1 hr., 1.5 hr, 2 hr., 2.5 hr, 3 hr., 3.5 hr, 4 hr., 4.5 hr., 5 hr., 5.5 hr, 6 hr., 6.5 hr, 7 hr., 7.5 hr, 8 hr., 8.5 hr, 9 hr., 9.5 hr or 10 hr, including any range defined between any two of the preceding values.
- the extract or composition is first heated to 90 degrees centigrade.
- the method comprises stirring and heating to at least 100 degrees centigrade.
- the process does not comprise the addition of a solvent, such as ethanol, butane, propane, isopropyl, or alcohol.
- a solvent such as ethanol, butane, propane, isopropyl, or alcohol.
- the process does not involve a use of a solvent between providing an extract or composition and production of D 8 THC.
- no organic solvent is employed during a heating step b).
- no organic solvent is employed during a, b, c, or d.
- no organic solvent is employed during the process.
- the extract or composition is CO 2 extracted from hemp.
- the extract or composition is CO 2 extracted from a plant.
- plants that are extracted are marijuana (cannabis) and hemp.
- D 9 THC levels in hemp are significantly lower than those in marijuana. The D 9 THC levels of hemp can rise if the plant becomes stressed by dry conditions, wind or other weather events.
- the extract or composition is decarboxylated.
- THC Tetrahydrocannabinolic acid
- THC Tetrahydrocannabinolic acid
- THCA contains an additional carboxyl group which makes for a different chemical structure compared to THC.
- THCA is the precursor to THC and it is converted to THC as it is exposed to heat and oxygen over time. This process is known as decarboxylation.
- THCA begins to convert to THC. Once dry, while there are trace amounts of THC in the plant, heating over time further converts THCA into THC.
- the extract or composition is CO 2 extracted from hemp and the extract or composition is then decarboxylated in order to produce the extract or composition used as the starting material.
- Some embodiments relate to a method of making D 8 THC, the method comprises:
- the extract or composition is heated to 70°C, 71°C, 72°C, 73°C, 74°C, 75°C, 76°C, 77°C, 78°C, 79°C, 80°C, 81°C, 82°C, 83°C, 84°C, 85°C, 86°C, 87°C, 88°C, 89°C, 90°C, 91°C, 92°C, 93°C, 94°C, 95°C, 96°C, 97°C, 98°C, 99°C, 100°C, 101°C, 102°C, 103°C, 104°C, 105°C, 106°C, 107°C, 108°C, 109°C, 110°C, 115°C, 120°C, 125°C, 130°C, 135°C, 140°C, 145°C, 150°C, 155°C, 160°C,
- the catalyst is a metallic catalyst.
- the metallic catalyst is selected from those known in the art of organic chemistry.
- the catalyst is a non-metal catalyst.
- the non-metal catalyst is selected from those known in the art of organic chemistry.
- the extract/composition : metallic catalyst ratio is 1:0.00001; 1:00005, 1:00010, 1:00015, 1:00020, 1:00025, 1:00030, 1:00035, 1:00040, 1:00045, 1:00050, 1:0010, 1:0015, 1:0020, 1:0025, 1:0050, 1:0100 or 1:0200.
- the heating is continued for 20 min., 25 min., 30 min., 35 min., 40 min., 45 min., 50 min., 55 min., 1 hr., 1.5 hr, 2 hr., 2.5 hr, 3 hr., 3.5 hr, 4 hr., 4.5 hr., 5 hr., 5.5 hr, 6 hr., 6.5 hr, 7 hr., 7.5 hr, 8 hr., 8.5 hr, 9 hr., 9.5 hr or 10 hr.
- the extract is a plant extract.
- Some embodiments relate to a method of making D 8 THC and/or CBN (and/or homologs thereof), the method comprising:
- CBD CBD (or a homolog thereof) is converted into D 8 THC and/or CBN (Cannabinol) (or a homolog thereof).
- the reaction is one as outlined in FIG. 1.
- the reaction is a method to convert a CBD homolog to one or both of a CBN homolog and/or a THC homolog, for example, as shown in FIG.1.
- CBD and numerous analogs thereof are well known (Morales et al. 2017 “An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol” Frontiers in Pharmacology 8: 422).
- the extract or composition is heated to 70°C, 71°C, 72°C, 73°C, 74°C, 75°C, 76°C, 77°C, 78°C, 79°C, 80°C, 81°C, 82°C, 83°C, 84°C, 85°C, 86°C, 87°C, 88°C, 89°C, 90°C, 91°C, 92°C, 93°C, 94°C, 95°C, 96°C, 97°C, 98°C, 99°C, 100°C, 101°C, 102°C, 103°C, 104°C, 105°C, 106°C, 107°C, 108°C, 109°C, 110°C, 115°C, 120°C, 125°C, 130°C, 135°C, 140°C, 145°C, 150°C, 155°C, 160°C,
- the ratio of halogen or a free radical generator to CBD is 0.0001:1, 0.0002:1, 0.0003:1, 0.0004:1, 0.0005:1, 0.0010:1, 0.0010:1, 0.0020:1, 0.0025:1, 0.0030:1, 0.0040:1, 0.0050:1 or 0.01:1.
- the halogen or a free radical generator is selected from iodine, and those known in the art of organic chemistry.
- CBD homolog is cannabidivarin (CBDV).
- the reaction produces at least Tetrahydrocannabivarin (THCV).
- the isolate comprises between 20-95% CBD (or CBDV).
- the isolate comprises 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90% or 95% CBD or an analog thereof, such as CBDV.
- the CBD is converted to D 8 THC.
- the halogen or a free radical generator comprises iodine.
- At least 50% of the CBD is converted to D 8 THC.
- At least 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98% or 99% of the CBD is converted to D 8 THC.
- At least 99% of the CBD is converted to D 8 THC. In some examples, at least 90% of the CBD is converted to D 8 THC. In some examples, substantially all CBD is converted to D 8 THC and CBN. In some examples, substantially all CBDV is converted to D 8 THCV and CBV. In some examples, CBDV is converted to D 8 THCV and CBV. [0158] In some examples, the isolate is heated to at least 70 degrees centigrade.
- the isolate is heated to at least 70°C, 71°C, 72°C, 73°C, 74°C, 75°C, 76°C, 77°C, 78°C, 79°C, 80°C, 81°C, 82°C, 83°C, 84°C, 85°C, 86°C, 87°C, 88°C, 89°C, 90°C, 91°C, 92°C, 93°C, 94°C, 95°C, 96°C, 97°C, 98°C, 99°C, 100°C, 101°C, 102°C, 103°C, 104°C, 105°C, 106°C, 107°C, 108°C, 109°C, 110°C, 115°C, 120°C, 125°C, 130°C, 135°C, 140°C, 145°C, 150°C, 155°C, 160°C,
- At least 1.0 g of iodine is employed.
- At least 0.1 g, 0.2 g, 0.3 g, 0.4 g, 0.5 g, 0.6 g, 0.7 g, 0.8 g, 0.9 g, 1.0 g. 1.5 g, 2.0 g, 2.5 g, 3.0 g, 3.5 g, 4.0 g, 4.5 g, 5.0 g or 10 g of iodine is employed, including any range defined between any two of the preceding values
- At least ratio of 0.001:1 w/w of iodine to CBD (or CBDV) isolate is used.
- the w/w ratio of iodine to CBD (or CBDV) in the isolate is 0.0001:1, 0.0005:1, 0.0010:1, 0.0015:1, 0.0020:1, 0.0025:1, 0.0030:1, 0.0035:1, 0.0040:1, 0.0045:1, 0.0050:1, 0.0055:1, 0.0060:1, 0.0065:1, 0.0070:1, 0.0075:1, 0.0080:1, 0.0085:1, 0.0090:1, 0.0095:1, 0.0100:1, 0.0150:1, 0.0200:1, 0.0250:1, 0.0300:1, 0.0500:1, 0.1000:1, 0.5000:1, 1:1, 2:1, 3:1, 4:1, 5:1, 6:1, 7:1, 8:1, 9:1 or 10:1, including any range defined between any two of the preceding values
- iodine to CBD (or CBDV) isolate is used.
- the CBD isolate (or CBDV isolate) is between 20 and 99% CBD and comprises at least one of propane or butane.
- the CBD isolate (or CBDV isolate) is 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98% or 99%, including any range defined between any two of the preceding values
- the reaction is carried out between 1 torr and 3 million torr. [0168] In some examples, the reaction is carried out at a pressure of about 1 torr, 2 torr, 3 torr, 4 torr, 5 torr, 6 torr, 7 torr, 8 torr, 9 torr, 10 torr, 20 torr, 30 torr, 40 torr, 50 torr, 60 torr, 70 torr, 80 torr, 90 torr, 100 torr, 200 torr, 300 torr, 400 torr, 500 torr, 600 torr, 700 torr, 800 torr, 900 torr, 1 x 10 3 torr, 5 x 10 3 torr, 1 x 10 4 torr, 5 x 10 4 torr, 1 x 10 5 torr, 5 x 10 5 torr, 1 x 10 6 torr, 2 x 10 6 torr or 3 x
- the method further comprises the addition of sodium thiosulphate as a quencher.
- the isolate is prepared by CO 2 extraction.
- the isolate is first heated to at least 55 degrees centigrade for 20 minutes while stirring and then heated to at least 55 centigrade for at least 20 minutes.
- the extract or composition is heated to 55°C, 56°C, 57°C, 58°C, 59°C, 60°C, 61°C, 62°C, 63°C, 64°C, 65°C, 66°C, 67°C, 68°C, 69°C, 70°C, 71°C, 72°C, 73°C, 74°C, 75°C, 76°C, 77°C, 78°C, 79°C, 80°C, 81°C, 82°C, 83°C, 84°C, 85°C, 86°C, 87°C, 88°C, 89°C, 90°C, 91°C, 92°C, 93°C, 94°C, 95°C, 96°C, 97°C, 98°C, 99°C, 100°C, 101°C, 102°C, 103°C, 104°C, 105°C, 100°C, 101°C
- the heating is continued for 20 min., 25 min., 30 min., 35 min., 40 min., 45 min., 50 min., 55 min., 1 hr., 1.5 hr, 2 hr., 2.5 hr, 3 hr., 3.5 hr, 4 hr., 4.5 hr., 5 hr., 5.5 hr, 6 hr., 6.5 hr, 7 hr., 7.5 hr, 8 hr., 8.5 hr, 9 hr., 9.5 hr or 10 hr, including any range defined between any two of the preceding values
- the isolate is first heated to 90 degrees centigrade.
- the process does not comprise the addition of a solvent.
- the process is performed in a solvent.
- the isolate is decarboxylated.
- Some embodiments relate to a method of making D 8 THC and/or CBN or a homolog thereof, the method comprising:
- CBD or homolog thereof is converted into D 8 THC (or a homolog thereof) and/or CBN (or a homolog thereof).
- the extract or composition is heated to 55°C, 56°C, 57°C, 58°C, 59°C, 60°C, 61°C, 62°C, 63°C, 64°C, 65°C, 66°C, 67°C, 68°C, 69°C, 70°C, 71°C, 72°C, 73°C, 74°C, 75°C, 76°C, 77°C, 78°C, 79°C, 80°C, 81°C, 82°C, 83°C, 84°C, 85°C, 86°C, 87°C, 88°C, 89°C, 90°C, 91°C, 92°C, 93°C, 94°C, 95°C, 96°C, 97°C, 98°C, 99°C, 100°C, 101°C, 102°C, 103°C, 104°C, 105°C, 100°C, 101°C
- the heating is continued for 20 min., 25 min., 30 min., 35 min., 40 min., 45 min., 50 min., 55 min., 1 hr., 1.5 hr, 2 hr., 2.5 hr, 3 hr., 3.5 hr, 4 hr., 4.5 hr., 5 hr., 5.5 hr, 6 hr., 6.5 hr, 7 hr., 7.5 hr, 8 hr., 8.5 hr, 9 hr., 9.5 hr or 10 hr.
- the isolate is from a plant.
- the plant is selected from marijuana (cannabis) and hemp.
- Example 1 In lieu of the isolate, a plant extract is used instead of the isolate.
- An extract is obtained that comprises at least one of delta 9 tetrahydrocannabinol ( D 9 THC) or a cannabidiol (CBD).
- D 9 THC delta 9 tetrahydrocannabinol
- CBD cannabidiol
- the extract is heated to at least 70 degrees centigrade to make a heated extract.
- At least 0.0005:1 weight to weight of iodine to CBD is added to the heated extract.
- the heated extract is for at least 20 minutes while stirring, such that the ( D 9 THC or CBD is converted into D8 THC, delta 10 tetrahydrocannabinol ( D 10 THC) and/or cannabinol (CBN).
- D 9 THC or CBD is converted into D8 THC, delta 10 tetrahydrocannabinol ( D 10 THC) and/or cannabinol (CBN).
- An extract is obtained that comprises at least one of D 9 THC or a CBD;
- the extract is heated to at least 70 degrees centigrade to make a heated extract.
- a catalyst is added to the heated extract or composition, wherein the extract or composition to catalyst is present in a ratio of about 1 : 0.0005 (grams of extract or composition to grams of catalyst) to about 1:1 (grams of extract or composition to grams of catalyst).
- An isolate is obtained that comprises at least a CBD (or a homolog thereof).
- the isolate is heated to between 55 and 800 degrees centigrade to make a heated isolate
- the isolate is heated for an additional at least 30 minutes, such that the CBD (or a homolog thereof) is converted into D 8 THC and/or CBN (Cannabinol) (or a homolog thereof).
- Example 4 Method of making D 8 THC and/or CBN or a homolog thereof
- An isolate is obtained that comprises a CBD or a homolog thereof.
- the isolate is heated to at least 55 degrees centigrade to make a heated isolate.
- a free radical generator is added to the heated isolate, wherein the isolate to free radical generator is present in a ratio of about 1:0.0001 (grams of isolate to grams of free radical generator) to about 1:10 (grams of isolate to grams of free radical generator).
- the isolate is heated for an additional at least 20 minutes while stirring, such that the CBD or homolog thereof is converted into D8 THC (or a homolog thereof) and/or CBN (or a homolog thereof).
- Example 1-4 can be employed for the reaction scheme noted above in the alternative. This allows for the conversion of a CBD homolog to one or both of a CBN homolog and/or a THC homolog (as shown in FIG.1).
- FIG. 1 While various embodiments are provided herein in terms of an isolate, in some embodiments, any one of these embodiments can be modified and applied to an extract.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Botany (AREA)
- Chemical & Material Sciences (AREA)
- Environmental Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Physiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A method of making delta 8 tetrahydrocannabinol (Δ8 THC) or homologs thereof, delta 10 tetrahydrocannabinol (Δ10 THC) or homologs thereof and/or cannabinol (CBN) or homologs thereof, the method including: a) providing an extract or composition that comprises at least one of delta 9 tetrahydrocannabinol (Δ9 THC) or homologs thereof or a cannabidiol (CBD) or homologs thereof; b) heating the extract or composition; c) adding iodine to CBD or homologs thereof to the heated extract or composition; and d) continuing to heat while stirring, such that the (Δ9 THC or CBD or homologs thereof is converted into Δ8 THC, delta 10 tetrahydrocannabinol (Δ10 THC) and/or cannabinol (CBN) (including or homologs thereof of any of the preceding). In some cases, a catalyst is added to the heated extract. In some cases, a halogen or a free radical generator is added to the heated isolate.
Description
MAKING DELTA 8 THC, DELTA 10 THC AND/OR CANNABINOL FROM CBD RELATED APPLICATIONS
[0001] This application claims priority to U.S. Provisional Applications Ser. No. 62/860,986, filed June 13, 2019, Ser. No. 62/869,698, filed July 2, 2019, and Ser. No. 62/871,427, filed July 8, 2019, each of which are hereby incorporated by reference in their entireties. BACKGROUND
Field
[0002] The present application relates to methods of making of delta 8 tetrahydrocannabinol ( D8 THC), delta 10 tetrahydrocannabinol ( D10 THC) and/or cannabinol (CBN) with or without using a solvent. Description of the Related Art
[0003] Delta-8-THC (D8 THC) is an analog of tetrahydrocannabinol (THC) with antiemetic, anxiolytic, appetite-stimulating, analgesic, and neuroprotective properties.D8 THC binds to the cannabinoid G-protein coupled receptor CB1, located in the central nervous system. This agent exhibits a lower psychotropic potency than Delta-9-THC (D9 THC), the primary form of THC found in cannabis. D8 THC is chemically different fromD9 THC by only a few atomic bonds. While D8 THC only exists naturally in fractions of a percent, it may be used in a variety of applications, offering unique effects. D10 THC is a derivative and isomer of CBD and D9 THC. Cannabinol (CBN) is a mildly psychoactive cannabinoid found only in trace amounts in Cannabis, mostly in aged Cannabis. SUMMARY
[0004] Some embodiments relate to a method of making delta 8 tetrahydrocannabinol (D8 THC), delta 10 tetrahydrocannabinol (D10 THC) and/or cannabinol (CBN), the method including:
a) providing an extract or composition that comprises at least one of delta 9 tetrahydrocannabinol (D9 THC) or a cannabidiol (CBD);
b) heating the extract or composition to at least 70 degrees centigrade to make a heated extract;
c) adding at least 0.0005:1 weight to weight of iodine to CBD to the heated extract or composition; and
d) continue heating for at least 20 minutes while stirring, such that the ( D9 THC or CBD is converted into D8 THC, delta 10 tetrahydrocannabinol ( D10 THC) and/or cannabinol (CBN).
[0005] In some examples, the extract or composition includes CBD.
[0006] In some examples, the CBD is converted to D8 THC.
[0007] In some examples, there is no significant amount of D9 THC in the product containing D8 THC.
[0008] In some examples, less than 0.3% w/w of D9 THC is present after the reaction.
[0009] In some examples, at least 50% of the CBD is converted to D8 THC.
[0010] In some examples, at least 99% of the CBD is converted to D8 THC.
[0011] In some examples, at least 90% of the CBD is converted to D8 THC.
[0012] In some examples, substantially all CBD is converted to D8 THC.
[0013] In some examples, the extract or composition is heated to at least 55 degrees centigrade.
[0014] In some examples, at least 1.0 g of iodine is employed.
[0015] In some examples, a ratio of 0.001:1 w/w of iodine to CBD is used.
[0016] In some examples, the method further includes the addition of calcium carbonate to the heated extract or composition.
[0017] In some examples, the method further includes the addition of sodium thiosulphate.
[0018] In some examples, the extract or composition is prepared by CO2 extraction.
[0019] In some examples, a ratio of 40 g of extract or composition is employed to 1.2g of elemental iodine.
[0020] In some examples, the extract or composition is first heated to at least 55 degrees centigrade for 20 minutes while stirring and then heated to at least 55 centigrade for at least 20 minutes.
[0021] In some examples, the extract or composition is first heated to 90 degrees centigrade.
[0022] In some examples, the method includes stirring and heating to at least 100 degrees centigrade.
[0023] In some examples, the process does not include the addition of a solvent.
[0024] In some examples, the process does not involve a use of a solvent between providing a extract or composition and production of D8 THC.
[0025] In some examples, no organic solvent is employed during a heating step b).
[0026] In some examples, no organic solvent is employed during d).
[0027] In some examples, no organic solvent is employed during a, b, c, or d.
[0028] In some examples, no organic solvent is employed during the process.
[0029] In some examples, the extract or composition is CO2 extracted from hemp.
[0030] In some examples, the extract or composition is decarboxylated.
[0031] In some examples, the extract or composition is CO2 extracted from hemp and the extract or composition is then decarboxlated in order to produce the extract or composition used as the starting material.
[0032] Some embodiments relate to a method of making D8 THC, the method including:
a) providing an extract or composition that comprises at least one of D9 THC or a CBD;
b) heating the extract or composition to at least 70 degrees centigrade to make a heated extract;
c) adding a catalyst to the heated extract or composition, wherein the extract or composition to catalyst is present in a ratio of about 1 : 0.0005 (grams of extract or
composition to grams of catalyst) to about 1:1 (grams of extract or composition to grams of catalyst); and
d) continue heating for at least 20 minutes while stirring, such that the D9 THC or CBD is converted into D8 THC, D10 THC and/or CBN.
[0033] In some examples, the catalyst is a metallic catalyst.
[0034] In some examples, the catalyst is a non-metallic catalyst.
[0035] In some examples, the extract is a plant extract.
[0036] Some embodiments relate to a method of making D8 THC and/or CBN (and/or homologs thereof), the method including:
a) providing an isolate that comprises at least a CBD (or a homolog thereof); b) heating the isolate to between 55 and 800 degrees centigrade to make a heated isolate;
c) adding between: 0.0001:1 (w/w) of a halogen or a free radical generator to CBD (or a homolog thereof) to 10:1 (w/w) of halogen or a free radical generator to CBD (or a homolog thereof) to the heated isolate; and
d) continue heating for at least 30 minutes such that the CBD (or a homolog thereof) is converted into D8 THC and/or CBN (Cannabinol) (or a homolog thereof).
[0037] In some embodiments, the CBD homolog is cannabidivarin (CBDV).
[0038] In some examples, the reaction produces at least Tetrahydrocannabivarin (THCV).
[0039] In some examples, the isolate comprises between 20-95% CBD (or CBDV).
[0040] In some examples, the CBD is converted to D8 THC.
[0041] In some examples, the halogen or a free radical generator includes iodine. In some embodiments, any of the embodiments provided herein regarding a halogen or free radical generator can employ a halogen containing molecule.
[0042] In some examples, there is no significant amount of D9 THC remaining.
[0043] In some examples, less than 0.3% w/w of D9 THC is present after the reaction.
[0044] In some examples, at least 50% of the CBD is converted to D8 THC.
[0045] In some examples, at least 99% of the CBD is converted to D8 THC.
[0046] In some examples, at least 90% of the CBD is converted to D8 THC.
[0047] In some examples, substantially all CBD is converted to D8 THC and CBN.
[0048] In some examples, substantially all CBDV is converted to D8 THCV and CBV.
[0049] In some examples, CBDV is converted to D8 THCV and CBV.
[0050] In some examples, the isolate is heated to at least 70 degrees centigrade.
[0051] In some examples, at least 1.0 g of iodine is employed.
[0052] In some examples, at least ratio of 0.001:1 w/w of iodine to CBD (or CBDV) isolate is used.
[0053] In some examples, less than a ratio of 10:1 w/w of iodine to CBD (or CBD) isolate is used.
[0054] In some examples, the CBD isolate (or CBDV isolate) is between 20 and 99% CBD and comprises at least one of propane or butane.
[0055] In some examples, the reaction is carried out between 1 torr and 3 million torr.
[0056] In some examples, the method further includes the addition of sodium thiosulphate as a quencher.
[0057] In some examples, the isolate is prepared by CO2 extraction.
[0058] In some examples, the isolate is first heated to at least 55 degrees centigrade for 20 minutes while stirring and then heated to at least 55 centigrade for at least 20 minutes.
[0059] In some examples, the isolate is first heated to 90 degrees centigrade.
[0060] In some examples, the process does not comprise the addition of a solvent.
[0061] In some examples, the process is performed in a solvent.
[0062] In some examples, the isolate is decarboxylated.
[0063] Some embodiments relate to a method of making D8 THC and/or CBN or a homolog thereof, the method comprising:
a) providing an isolate that comprises a CBD or a homolog thereof;
b) heating the isolate to at least 55 degrees centigrade to make a heated isolate;
c) adding a free radical generator to the heated isolate, wherein the isolate to free radical generator is present in a ratio of about 1:0.0001 (grams of isolate to grams of free radical generator) to about 1:10 (grams of isolate to grams of free radical generator); and
d) continue heating for at least 20 minutes while stirring, such that the CBD or homolog thereof is converted into D8 THC (or a homolog thereof) and/or CBN (or a homolog thereof).
[0064] In some examples, the isolate is from a plant.
[0065] In some examples, in lieu of the isolate, a plant extract is used instead. BRIEF DESCRIPTION OF THE DRAWINGS
[0066] FIG. 1 depicts some embodiments of a reaction scheme in which a“CBD homolog” (formula A) is converted to a“THC homolog” (including, for example, THCV) as in formula C and/or a“CBN homolog” (including, for example, CBV) as in formula D.
DETAILED DESCRIPTION
[0067] Provided herein are embodiments relating to the making of D8 THC, D10 THC and/or CBN via a solvent-less method. Some embodiments relate to using D9 THC or a CBD (cannabidiol) as a starting agent in the production of D8 THC, D10 THC and/or CBN via a solvent-less method.
[0068] In some embodiments, the methods involve heat and/or iodine (or any halogen or free radical generator as an alternative to iodine). In some embodiments, the method is applied to an isolate, which can include, for example, a hemp isolate. In some embodiments, the method is applied to any isolate, that has been isolated from, for example, hemp.
[0069] In some embodiments, the hemp isolate contains between 95 and 20% CBD in terms of purity. The isolate can also contain pentane and/or butane.
[0070] As disclosed herein, in some embodiments, the reaction starts with CBD and produces D8 THC and/or CBN. The method can be applied to homologs thereof. In some embodiments, the reaction starts with CBDV to convert it to D9 THCV and then onto D8 THCV and CBV (cannabidivarin). Any of the embodiments (including those in the claims) provided herein with respect to one of these embodiments can be applied to the homolog embodiments as well.
[0071] In some embodiments, the reaction to produce D8 THC and/cannabinol from CBD can be quenched with sodium thiosulfate.
[0072] In some embodiments, the method involves an isolate of greater than 95% purity of CBD that can be converted into D8 THC and CBN with (and optionally solely) using iodine (or other options provided herein) and heat.
[0073] An exemplary reaction is shown in the reaction diagram below. In some embodiments, R1 can be 5 carbons long (pentyl) and R2 can be 1 carbon long (methyl) for CBD. Further, this same reaction can work for CBDV to D9 THCV then onto D8 THCV and CBV (R1=3 carbons, R2=1 carbon). This reaction scheme can work for a variety of CBD homologs and the resulting homolog products.
[0074] In some embodiments, the reaction comprises or consists of that outlined below (and in FIG.1):
wherein, R1 and R2 can be any alkyl group. In some embodiments, R1 and R2 are separately selected from any alkyl that is 1-20 carbon atoms in length. The term“alkyl,” alone or in combination, refers to a fully saturated aliphatic. In certain embodiments, alkyls are optionally substituted. In certain embodiments, an alkyl comprises 1 to 20 carbon atoms (whenever it appears herein, a numerical range, such as“1 to 20” or“C1-C20”, refers to each integer in the given range; e.g.,“C1-C20 alkyl” means that an alkyl group comprising only 1 carbon atom, 2 carbon atoms, 3 carbon atoms, etc., up to and including 20 carbon atoms). Examples of alkyls include, but are not limited to, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, tert-amyl, pentyl, hexyl, heptyl, octyl and the like.
[0075] In some embodiments, any of the compounds provided with respect to the options of R1 and R2 in the reaction diagram above can be applied in the context of any one of more of the embodiments and claims recited herein (simply by inserting the particular starting formula and following the reaction through, in place of the CBD embodiments provided in the claims below. The term“CBD homolog” denotes those options encompassed within formula A above. The term“THC homolog” (such as THCV) denotes those options encompassed within formula C above. The term“CBN homolog” (such as CBV) denotes those options encompassed within formula D above. For the CBD to THC conversion, R1 is 5 and R2 is one carbon. In some embodiments, one can use any of the relevant methods provided herein to convert a CBD homolog to one or both of a CBN homolog and/or a THC homolog, for example, as shown in FIG.1.
[0076] In some embodiments, the method in FIG.1 further comprises:
a) providing an isolate that comprises the compound A (various homologs);
b) heating the isolate to between 55 and 800 degrees centigrade to make a heated isolate;
c) adding between: 0.0001:1 (w/w) of a halogen or a free radical generator to A to 10:1 (w/w) of halogen or a free radical generator to A to the heated isolate; and d) continue heating for at least 30 minutes such that the A is converted into C and/or D (e.g., Cannabinol) (or a homolog thereof).
[0077] In some embodiments, the reaction comprises or consists of that outlined below:
[0080] As used herein, CBD or homologs thereof denotes both the general class of CBD:
as well as, for example, cannabidivarin (CBDV):
[0082] In some embodiments, the reaction is a generalized reaction in the presence of iodine, or another halogen, or a free radical generating species. In some embodiments, the reaction is one as outlined in FIG.1. In some embodiments, the reaction is a method to convert a CBD homolog to one or both of a CBN homolog and/or a THC homolog, for example, as shown in FIG.1.
[0083] In some embodiments, the reaction is carried out under atmospheric pressure. In some embodiments, the reaction is carried out between 1 torr and 3 million torr.
In some embodiments, prior to adding the quencher, the reaction is allowed to continue for at least 30 minutes, for example, 0.5, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 24 hours or more, including 1, 2, 3, 4, 5, 6, 7 or more days, include 1, 2, or 3 or more months. In some embodiments, the reaction is one as outlined in FIG.1. In some embodiments, the reaction is a method to convert a CBD homolog to one or both of a CBN homolog and/or a THC homolog, for example, as shown in FIG.1.
[0084] In some embodiments, there is no base present during the conversion of CBD (or other homolog) to product. In some embodiments, the reaction is carried out under neutral or acidic conditions. In some embodiments, the reaction is one as outlined in FIG.1. In some embodiments, the reaction is a method to convert a CBD homolog to one or both of a CBN homolog and/or a THC homolog, for example, as shown in FIG.1.
[0085] In some embodiments, this is a one-pot process. In some embodiments, the reaction is one as outlined in FIG. 1. In some embodiments, the reaction is a method to convert a CBD homolog to one or both of a CBN homolog and/or a THC homolog, for example, as shown in FIG.1.
[0086] In some embodiments, unexpectedly, the oxane (tetrahydropyran) ring closure occurs (CBD to D9 THC) followed by an isomerization of the double bond around the 9th carbon (THC carbon numbering shown below).
[0087] In some embodiments, this produces a more potent local analgesic isomer from CBD, delta 8 THC when topically applied reduces inflammation and pain.
[0088] In the case of when CBDV is used as a starting compound (as a CBD homolog), the reaction produces an isomer (THCV) that increases sensitivity to insulin as well as functions as an appetite suppressant in higher doses.
[0089] In some embodiments, a method of making delta 8 tetrahydrocannabinol ( D8 THC) is provided. The method comprises:
a) providing an extract or composition that comprises at least one of delta 9 tetrahydrocannabinol ( D9 THC) or a cannabidiol (CBD);
b) heating the extract or composition to at least 70 degrees centigrade to make a heated extract;
c) adding at least 0.0005:1 weight to weight of iodine to CBD to the heated extract or composition; and
d) continue heating for at least 20 minutes while stirring, such that the ( D9 THC or CBD is converted into D8 THC, delta 10 tetrahydrocannabinol ( D10 THC) and/or cannabinol (CBN). In some embodiments, a-d can be applied to the homolog reaction process shown in FIG.1.
[0090] In some examples, the extract or composition is heated to 70°C, 71°C, 72°C, 73°C, 74°C, 75°C, 76°C, 77°C, 78°C, 79°C, 80°C, 81°C, 82°C, 83°C, 84°C, 85°C, 86°C, 87°C, 88°C, 89°C, 90°C, 91°C, 92°C, 93°C, 94°C, 95°C, 96°C, 97°C, 98°C, 99°C, 100°C, 101°C, 102°C, 103°C, 104°C, 105°C, 106°C, 107°C, 108°C, 109°C, 110°C, 115°C, 120°C, 125°C, 130°C, 135°C, 140°C, 145°C, 150°C, 155°C, 160°C, 165°C, 170°C, 175°C, 180°C, 185°C, 190°C, 195°C, 200°C, 250°C, 300°C, 350°C, 400°C, 450°C, 500°C, 550°C, 600°C, 650°C, 700°C, 750°C, 800°C or 850°C, including any range defined between any two of the preceding values. In some embodiments, the reaction is one as outlined in FIG. 1. In some embodiments, the reaction is a method to convert a CBD homolog to one or both of a CBN homolog and/or a THC homolog, for example, as shown in FIG.1.
[0091] In some examples, the w/w ratio of iodine to CBD to the heated extract or composition is 0.0005:1, 0.0010:1, 0.0015:1, 0.0020:1, 0.0025:1, 0.0030:1, 0.0035:1, 0.0040:1, 0.0045:1, 0.0050:1, 0.0055:1, 0.0060:1, 0.0065:1, 0.0070:1, 0.0075:1, 0.0080:1, 0.0085:1, 0.0090:1, 0.0095:1, 0.0100:1, 0.0150:1, 0.0200:1, 0.0250:1, 0.0300:1. In some embodiments, the reaction is one as outlined in FIG.1. In some embodiments, the reaction is a method to convert a CBD homolog to one or both of a CBN homolog and/or a THC homolog, for example, as shown in FIG.1.
[0092] In some examples, in step (d) the heating is continued for 20 min., 25 min., 30 min., 35 min., 40 min., 45 min., 50 min., 55 min., 1 hr., 1.5 hr, 2 hr., 2.5 hr, 3 hr., 3.5 hr, 4 hr., 4.5 hr., 5 hr., 5.5 hr, 6 hr., 6.5 hr, 7 hr., 7.5 hr, 8 hr., 8.5 hr, 9 hr., 9.5 hr,10 hr, 12 hr, 13hr, 14 hr, 15 hr, 16 hr, 17 hr, 18 hr, 19 hr, 20 hr, 21 hr, 22 hr, 23 hr, 24 hr, 48 hr or 72 hr, including any range defined between any two of the preceding values. In some embodiments, the reaction is one as outlined in FIG.1. In some embodiments, the reaction is a method to convert a CBD homolog to one or both of a CBN homolog and/or a THC homolog, for example, as shown in FIG.1.
[0093] In some examples, the extract or composition comprises CBD.
[0094] In some examples, the CBD is converted to D8 THC.
[0095] In some examples, the amount of CBD converted to D8 THC is 1%, 2%, 5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99%, 99.9%, 99.99%, 99.999%, or greater. In some embodiments, the reaction is one as outlined in FIG.1. In some embodiments, the reaction is a method to convert a CBD homolog to one or both of a CBN homolog and/or a THC homolog, for example, as shown in FIG.1.
[0096] In some examples, there is no significant amount of D9 THC in the product containing D8 THC.
[0097] In some examples, there is less than 0.3% w/w of D9 THC present after the reaction.
[0098] In some examples, there is less than 0.25%, 0.20%, 0.15%, 0.10%, 0.05%, 0.02%, 0.01%, 0.005%, 0.0025% or 0.0010% w/w of D9 THC present after the reaction.
[0099] In some examples, at least 50% of the CBD is converted to D8 THC.
[0100] In some examples, at least 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90% 95%, 96% 97%, 98%, 99%, 99.9%, 99.99%, 99.999%, or greater of the CBD is converted to D8 THC. In some examples, at least 99% of the CBD is converted to D8 THC. In some examples, at least 90% of the CBD is converted to D8 THC. In some examples, substantially all CBD is converted to D8 THC. In some examples, the extract or composition is heated to at least 55 degrees centigrade.
[0101] In some examples, the extract or composition is heated to 55°C, 56°C, 57°C, 58°C, 59°C, 60°C, 61°C, 62°C, 63°C, 64°C, 65°C, 66°C, 67°C, 68°C, 69°C, 70°C, 71°C, 72°C, 73°C, 74°C, 75°C, 76°C, 77°C, 78°C, 79°C, 80°C, 81°C, 82°C, 83°C, 84°C, 85°C, 86°C, 87°C, 88°C, 89°C, 90°C, 91°C, 92°C, 93°C, 94°C, 95°C, 96°C, 97°C, 98°C, 99°C, 100°C, 101°C, 102°C, 103°C, 104°C, 105°C, 106°C, 107°C, 108°C, 109°C, 110°C, 115°C, 120°C, 125°C, 130°C, 135°C, 140°C, 145°C, 150°C, 155°C, 160°C, 165°C, 170°C, 175°C, 180°C, 185°C, 190°C, 195°C or 200°C, including any range defined between any two of the preceding values
[0102] In some examples, at least 1.0 g of iodine is employed. In some examples, at least 0.1 g, 0.2 g, 0.3 g, 0.4 g, 0.5 g, 0.6 g, 0.7 g, 0.8 g, 0.9 g, 1.0 g. 1.5 g, 2.0 g, 2.5 g, 3.0 g, 3.5 g, 4.0 g, 4.5 g, 5.0 g or 10 g of iodine is employed.
[0103] In some examples, a ratio of 0.001:1 w/w of iodine to CBD is used. In some examples, the w/w ratio of iodine to CBD to the heated extract or composition is 0.0001:1, 0.0005:1, 0.0010:1, 0.0015:1, 0.0020:1, 0.0025:1, 0.0030:1, 0.0035:1, 0.0040:1, 0.0045:1, 0.0050:1, 0.0055:1, 0.0060:1, 0.0065:1, 0.0070:1, 0.0075:1, 0.0080:1, 0.0085:1, 0.0090:1, 0.0095:1, 0.0100:1, 0.0150:1, 0.0200:1, 0.0250:1, 0.0300:1, 0.0500:1, 0.1000:1, 0.5000:1, 1:1, 2:1, 3:1, 4:1, 5:1, 6:1, 7:1, 8:1, 9:1 or 10:1.
[0104] In some examples, the method further comprises the addition of calcium carbonate to the heated extract or composition.
[0105] In some examples, then method further comprises the addition of sodium thiosulphate.
[0106] In some examples, the extract or composition is prepared by CO2 extraction.
[0107] Cannabis oil is usually extracted on a commercial scale either through the use of solvents such as hexane or butane, or through more modern supercritical/subcritical CO2 (carbon dioxide) processes.
[0108] Carbon dioxide-based extraction is considered to be more environmentally friendly, considerably safer, cleaner, cheaper and less toxic than using fossil fuel-based extraction, and results in a consistent product that is more palatable.
[0109] At standard temperatures and pressure, carbon dioxide is a gas. At 60.4 psi it is a liquid and at -78°C, at standard pressure, it is a solid (dry ice).
[0110] When heated to above 31.10°C (critical temperature) and at 1,071 psi (critical pressure) or higher, it has the properties of both a gas and liquid. It becomes a supercritical liquid.
[0111] Supercritical liquids can pass through porous solids and also dissolve materials, making them ideal as a solvent. The“tunability” of supercritical CO2 extraction enables targeting maximum outputs of cannabidiol depending on the type and quality of cannabis material being used; while keeping undesirable compounds such as chlorophyll out of the product.
[0112] The following is an example outline of a supercritical CO2 extraction process:
i. An extractor chamber is filled with ground cannabis/hemp material (called trim).
ii. A pump forces pressurized carbon dioxide gas at the optimum supercritical temperature (ScCO2) into the extractor chamber.
iii. The supercritical carbon dioxide interacts with the cannabis, dissolving the cannabinoid compounds it contains.
iv. The supercritical CO2 carries the cannabis oil particles past a pressure release valve to a cyclonic separator.
v. In the separator, the pressure is lower and the carbon dioxide and cannabis oil separates.
vi. The carbon dioxide rises and is routed back to the CO2 tank for reuse in the case of a closed loop system.
vii. The cannabis oil, waxes and resins descend in the separator where they are captured by a collection vessel.
viii. The resulting substance is processed further into various products, such as CBD-rich“cannabis oil”, free of any solvents.
[0113] In some examples, a ratio of 40 g of extract or composition is employed to 1.2g of elemental iodine (i.e., a 33.33:1 ratio of extract/composition to elemental iodine).
[0114] In some embodiments, the ratio of extract/composition to elemental iodine is 5:1, 10:1, 15:1, 20:1, 25:1, 30:1, 35:1, 40:1, 45:1, 50:1, 55:1, 60:1, 65:1, 70:1, 75:1, 80:1, 85:1, 90:1, 95:1 or 100:1.
[0115] In some examples, the extract or composition is first heated to at least 55 degrees centigrade for 20 minutes while stirring and then heated to at least 55 centigrade for at least 20 minutes.
[0116] In some embodiments, the extract or composition is heated to 55°C, 56°C, 57°C, 58°C, 59°C, 60°C, 61°C, 62°C, 63°C, 64°C, 65°C, 66°C, 67°C, 68°C, 69°C, 70°C, 71°C, 72°C, 73°C, 74°C, 75°C, 76°C, 77°C, 78°C, 79°C, 80°C, 81°C, 82°C, 83°C, 84°C, 85°C, 86°C, 87°C, 88°C, 89°C, 90°C, 91°C, 92°C, 93°C, 94°C, 95°C, 96°C, 97°C, 98°C, 99°C, 100°C, 101°C, 102°C, 103°C, 104°C, 105°C, 106°C, 107°C, 108°C, 109°C, 110°C, 115°C, 120°C, 125°C, 130°C, 135°C, 140°C, 145°C, 150°C, 155°C, 160°C, 165°C, 170°C,
175°C, 180°C, 185°C, 190°C, 195°C or 200°C, including any range defined between any two of the preceding values
[0117] In some examples, the heating is continued for 20 min., 25 min., 30 min., 35 min., 40 min., 45 min., 50 min., 55 min., 1 hr., 1.5 hr, 2 hr., 2.5 hr, 3 hr., 3.5 hr, 4 hr., 4.5 hr., 5 hr., 5.5 hr, 6 hr., 6.5 hr, 7 hr., 7.5 hr, 8 hr., 8.5 hr, 9 hr., 9.5 hr or 10 hr, including any range defined between any two of the preceding values.
[0118] In some examples, the extract or composition is first heated to 90 degrees centigrade.
[0119] In some examples, the method comprises stirring and heating to at least 100 degrees centigrade.
[0120] In some examples, the process does not comprise the addition of a solvent, such as ethanol, butane, propane, isopropyl, or alcohol.
[0121] In some examples, the process does not involve a use of a solvent between providing an extract or composition and production of D8 THC.
[0122] In some examples, no organic solvent is employed during a heating step b).
[0123] In some examples, no organic solvent is employed during d).
[0124] In some examples, no organic solvent is employed during a, b, c, or d.
[0125] In some examples, no organic solvent is employed during the process.
[0126] In some examples, the extract or composition is CO2 extracted from hemp.
[0127] In some examples, the extract or composition is CO2 extracted from a plant. Non-limiting examples of plants that are extracted are marijuana (cannabis) and hemp. D9 THC levels in hemp are significantly lower than those in marijuana. The D9 THC levels of hemp can rise if the plant becomes stressed by dry conditions, wind or other weather events.
[0128] In some examples, the extract or composition is decarboxylated.
[0129] Tetrahydrocannabinolic acid (THCA) is the precursor to THC, which is found in the trichomes of living hemp and cannabis plants. THCA contains an additional carboxyl group which makes for a different chemical structure compared to THC. THCA is the precursor to THC and it is converted to THC as it is exposed to heat and oxygen over time. This process is known as decarboxylation. After a cannabis plant is harvested and
begins the drying process, THCA begins to convert to THC. Once dry, while there are trace amounts of THC in the plant, heating over time further converts THCA into THC.
[0130] In some examples, the extract or composition is CO2 extracted from hemp and the extract or composition is then decarboxylated in order to produce the extract or composition used as the starting material.
[0131] Some embodiments relate to a method of making D8 THC, the method comprises:
a) providing an extract or composition that comprises at least one of D9 THC or a CBD;
b) heating the extract or composition to at least 70 degrees centigrade to make a heated extract;
c) adding a catalyst to the heated extract or composition, wherein the extract or composition to catalyst is present in a ratio of about 1 : 0.0005 (grams of extract or composition to grams of catalyst) to about 1:1 (grams of extract or composition to grams of catalyst); and
d) continue heating for at least 20 minutes while stirring, such that the D9 THC or CBD is converted into D8 THC, D10 THC and/or CBN.
[0132] In some examples, the extract or composition is heated to 70°C, 71°C, 72°C, 73°C, 74°C, 75°C, 76°C, 77°C, 78°C, 79°C, 80°C, 81°C, 82°C, 83°C, 84°C, 85°C, 86°C, 87°C, 88°C, 89°C, 90°C, 91°C, 92°C, 93°C, 94°C, 95°C, 96°C, 97°C, 98°C, 99°C, 100°C, 101°C, 102°C, 103°C, 104°C, 105°C, 106°C, 107°C, 108°C, 109°C, 110°C, 115°C, 120°C, 125°C, 130°C, 135°C, 140°C, 145°C, 150°C, 155°C, 160°C, 165°C, 170°C, 175°C, 180°C, 185°C, 190°C, 195°C or 200°C.
[0133] In some embodiments, the catalyst is a metallic catalyst.
[0134] In some examples, the metallic catalyst is selected from those known in the art of organic chemistry.
[0135] In some embodiments, the catalyst is a non-metal catalyst.
[0136] In some examples, the non-metal catalyst is selected from those known in the art of organic chemistry.
[0137] In some examples, the extract/composition : metallic catalyst ratio is 1:0.00001; 1:00005, 1:00010, 1:00015, 1:00020, 1:00025, 1:00030, 1:00035, 1:00040, 1:00045, 1:00050, 1:0010, 1:0015, 1:0020, 1:0025, 1:0050, 1:0100 or 1:0200.
[0138] In some examples, the heating is continued for 20 min., 25 min., 30 min., 35 min., 40 min., 45 min., 50 min., 55 min., 1 hr., 1.5 hr, 2 hr., 2.5 hr, 3 hr., 3.5 hr, 4 hr., 4.5 hr., 5 hr., 5.5 hr, 6 hr., 6.5 hr, 7 hr., 7.5 hr, 8 hr., 8.5 hr, 9 hr., 9.5 hr or 10 hr.
[0139] In some examples, the extract is a plant extract.
[0140] Some embodiments relate to a method of making D8 THC and/or CBN (and/or homologs thereof), the method comprising:
a) providing an isolate that comprises at least a CBD (or a homolog thereof); b) heating the isolate to between 55 and 800 degrees centigrade to make a heated isolate;
c) adding between 0.0001:1 (w/w) of a halogen or a free radical generator to CBD (or a homolog thereof) to 10:1 (w/w) of halogen or a free radical generator to CBD (or a homolog thereof) to the heated isolate; and
d) continue heating for at least 30 minutes such that the CBD (or a homolog thereof) is converted into D8 THC and/or CBN (Cannabinol) (or a homolog thereof).
[0141] In some embodiments, the reaction is one as outlined in FIG. 1. In some embodiments, the reaction is a method to convert a CBD homolog to one or both of a CBN homolog and/or a THC homolog, for example, as shown in FIG.1.
[0142] CBD and numerous analogs thereof are well known (Morales et al. 2017 “An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol” Frontiers in Pharmacology 8: 422).
[0143] In some examples, the extract or composition is heated to 70°C, 71°C, 72°C, 73°C, 74°C, 75°C, 76°C, 77°C, 78°C, 79°C, 80°C, 81°C, 82°C, 83°C, 84°C, 85°C, 86°C, 87°C, 88°C, 89°C, 90°C, 91°C, 92°C, 93°C, 94°C, 95°C, 96°C, 97°C, 98°C, 99°C, 100°C, 101°C, 102°C, 103°C, 104°C, 105°C, 106°C, 107°C, 108°C, 109°C, 110°C, 115°C, 120°C, 125°C, 130°C, 135°C, 140°C, 145°C, 150°C, 155°C, 160°C, 165°C, 170°C, 175°C, 180°C, 185°C, 190°C, 195°C, 200°C, 250°C, 300°C, 350°C, 400°C, 450°C, 500°C, 550°C, 600°C, 650°C, 700°C, 750°C, 800°C or 850°C.
[0144] In some examples, the ratio of halogen or a free radical generator to CBD (or a homolog thereof) is 0.0001:1, 0.0002:1, 0.0003:1, 0.0004:1, 0.0005:1, 0.0010:1, 0.0010:1, 0.0020:1, 0.0025:1, 0.0030:1, 0.0040:1, 0.0050:1 or 0.01:1.
[0145] In some examples, the halogen or a free radical generator is selected from iodine, and those known in the art of organic chemistry.
[0146] In some examples, the CBD homolog is cannabidivarin (CBDV).
[0147] In some examples, the reaction produces at least Tetrahydrocannabivarin (THCV).
[0148] In some examples, the isolate comprises between 20-95% CBD (or CBDV).
[0149] In some examples, the isolate comprises 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90% or 95% CBD or an analog thereof, such as CBDV.
[0150] In some examples, the CBD is converted to D8 THC.
[0151] In some examples, the halogen or a free radical generator comprises iodine.
[0152] In some examples, there is no significant amount of D9 THC remaining.
[0153] In some examples, less than 0.3% w/w of D9 THC is present after the reaction.
[0154] In some examples, less than 0.001%, 0.005%, 0.010%, 0.020%, 0.030%, 0.040%, 0.050%, 0.100%, 0.150%, 0.200%, 0.250% or 0.300%, w/w of D9 THC is present after the reaction.
[0155] In some examples, at least 50% of the CBD is converted to D8 THC.
[0156] In some examples, at least 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98% or 99% of the CBD is converted to D8 THC.
[0157] In some examples, at least 99% of the CBD is converted to D8 THC. In some examples, at least 90% of the CBD is converted to D8 THC. In some examples, substantially all CBD is converted to D8 THC and CBN. In some examples, substantially all CBDV is converted to D8 THCV and CBV. In some examples, CBDV is converted to D8 THCV and CBV.
[0158] In some examples, the isolate is heated to at least 70 degrees centigrade.
[0159] In some embodiments, the isolate is heated to at least 70°C, 71°C, 72°C, 73°C, 74°C, 75°C, 76°C, 77°C, 78°C, 79°C, 80°C, 81°C, 82°C, 83°C, 84°C, 85°C, 86°C, 87°C, 88°C, 89°C, 90°C, 91°C, 92°C, 93°C, 94°C, 95°C, 96°C, 97°C, 98°C, 99°C, 100°C, 101°C, 102°C, 103°C, 104°C, 105°C, 106°C, 107°C, 108°C, 109°C, 110°C, 115°C, 120°C, 125°C, 130°C, 135°C, 140°C, 145°C, 150°C, 155°C, 160°C, 165°C, 170°C, 175°C, 180°C, 185°C, 190°C, 195°C, 200°C, 250°C, 300°C, 350°C, 400°C, 450°C, 500°C, 550°C, 600°C, 650°C, 700°C, 750°C, 800°C or 850°C, including any range defined between any two of the preceding values
[0160] In some examples, at least 1.0 g of iodine is employed.
[0161] In some examples, at least 0.1 g, 0.2 g, 0.3 g, 0.4 g, 0.5 g, 0.6 g, 0.7 g, 0.8 g, 0.9 g, 1.0 g. 1.5 g, 2.0 g, 2.5 g, 3.0 g, 3.5 g, 4.0 g, 4.5 g, 5.0 g or 10 g of iodine is employed, including any range defined between any two of the preceding values
[0162] In some examples, at least ratio of 0.001:1 w/w of iodine to CBD (or CBDV) isolate is used.
[0163] In some examples, the w/w ratio of iodine to CBD (or CBDV) in the isolate is 0.0001:1, 0.0005:1, 0.0010:1, 0.0015:1, 0.0020:1, 0.0025:1, 0.0030:1, 0.0035:1, 0.0040:1, 0.0045:1, 0.0050:1, 0.0055:1, 0.0060:1, 0.0065:1, 0.0070:1, 0.0075:1, 0.0080:1, 0.0085:1, 0.0090:1, 0.0095:1, 0.0100:1, 0.0150:1, 0.0200:1, 0.0250:1, 0.0300:1, 0.0500:1, 0.1000:1, 0.5000:1, 1:1, 2:1, 3:1, 4:1, 5:1, 6:1, 7:1, 8:1, 9:1 or 10:1, including any range defined between any two of the preceding values
[0164] In some examples, less than a ratio of 10:1 w/w of iodine to CBD (or CBDV) isolate is used.
[0165] In some examples, the CBD isolate (or CBDV isolate) is between 20 and 99% CBD and comprises at least one of propane or butane.
[0166] In some examples, the CBD isolate (or CBDV isolate) is 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98% or 99%, including any range defined between any two of the preceding values
[0167] In some examples, the reaction is carried out between 1 torr and 3 million torr.
[0168] In some examples, the reaction is carried out at a pressure of about 1 torr, 2 torr, 3 torr, 4 torr, 5 torr, 6 torr, 7 torr, 8 torr, 9 torr, 10 torr, 20 torr, 30 torr, 40 torr, 50 torr, 60 torr, 70 torr, 80 torr, 90 torr, 100 torr, 200 torr, 300 torr, 400 torr, 500 torr, 600 torr, 700 torr, 800 torr, 900 torr, 1 x 103 torr, 5 x 103 torr, 1 x 104 torr, 5 x 104 torr, 1 x 105 torr, 5 x 105 torr, 1 x 106 torr, 2 x 106 torr or 3 x 106 torr, including any range defined between any two of the preceding values
[0169] In some examples, the method further comprises the addition of sodium thiosulphate as a quencher.
[0170] In some examples, the isolate is prepared by CO2 extraction.
[0171] In some examples, the isolate is first heated to at least 55 degrees centigrade for 20 minutes while stirring and then heated to at least 55 centigrade for at least 20 minutes.
[0172] In some embodiments, the extract or composition is heated to 55°C, 56°C, 57°C, 58°C, 59°C, 60°C, 61°C, 62°C, 63°C, 64°C, 65°C, 66°C, 67°C, 68°C, 69°C, 70°C, 71°C, 72°C, 73°C, 74°C, 75°C, 76°C, 77°C, 78°C, 79°C, 80°C, 81°C, 82°C, 83°C, 84°C, 85°C, 86°C, 87°C, 88°C, 89°C, 90°C, 91°C, 92°C, 93°C, 94°C, 95°C, 96°C, 97°C, 98°C, 99°C, 100°C, 101°C, 102°C, 103°C, 104°C, 105°C, 106°C, 107°C, 108°C, 109°C, 110°C, 115°C, 120°C, 125°C, 130°C, 135°C, 140°C, 145°C, 150°C, 155°C, 160°C, 165°C, 170°C, 175°C, 180°C, 185°C, 190°C, 195°C or 200°C, including any range defined between any two of the preceding values
[0173] In some examples, the heating is continued for 20 min., 25 min., 30 min., 35 min., 40 min., 45 min., 50 min., 55 min., 1 hr., 1.5 hr, 2 hr., 2.5 hr, 3 hr., 3.5 hr, 4 hr., 4.5 hr., 5 hr., 5.5 hr, 6 hr., 6.5 hr, 7 hr., 7.5 hr, 8 hr., 8.5 hr, 9 hr., 9.5 hr or 10 hr, including any range defined between any two of the preceding values
[0174] In some examples, the isolate is first heated to 90 degrees centigrade.
[0175] In some examples, the process does not comprise the addition of a solvent.
[0176] In some examples, the process is performed in a solvent.
[0177] In some examples, the isolate is decarboxylated.
[0178] Some embodiments relate to a method of making D8 THC and/or CBN or a homolog thereof, the method comprising:
a) providing an isolate that comprises a CBD or a homolog thereof;
b) heating the isolate to at least 55 degrees centigrade to make a heated isolate;
c) adding a free radical generator to the heated isolate, wherein the isolate to free radical generator is present in a ratio of about 1:0.0001 (grams of isolate to grams of free radical generator) to about 1:10 (grams of isolate to grams of free radical generator); and
d) continue heating for at least 20 minutes while stirring, such that the CBD or homolog thereof is converted into D8 THC (or a homolog thereof) and/or CBN (or a homolog thereof).
[0179] In some embodiments, the extract or composition is heated to 55°C, 56°C, 57°C, 58°C, 59°C, 60°C, 61°C, 62°C, 63°C, 64°C, 65°C, 66°C, 67°C, 68°C, 69°C, 70°C, 71°C, 72°C, 73°C, 74°C, 75°C, 76°C, 77°C, 78°C, 79°C, 80°C, 81°C, 82°C, 83°C, 84°C, 85°C, 86°C, 87°C, 88°C, 89°C, 90°C, 91°C, 92°C, 93°C, 94°C, 95°C, 96°C, 97°C, 98°C, 99°C, 100°C, 101°C, 102°C, 103°C, 104°C, 105°C, 106°C, 107°C, 108°C, 109°C, 110°C, 115°C, 120°C, 125°C, 130°C, 135°C, 140°C, 145°C, 150°C, 155°C, 160°C, 165°C, 170°C, 175°C, 180°C, 185°C, 190°C, 195°C or 200°C.
[0180] In some examples, the heating is continued for 20 min., 25 min., 30 min., 35 min., 40 min., 45 min., 50 min., 55 min., 1 hr., 1.5 hr, 2 hr., 2.5 hr, 3 hr., 3.5 hr, 4 hr., 4.5 hr., 5 hr., 5.5 hr, 6 hr., 6.5 hr, 7 hr., 7.5 hr, 8 hr., 8.5 hr, 9 hr., 9.5 hr or 10 hr.
[0181] In some examples, the isolate is from a plant.
[0182] In some non-limiting examples, the plant is selected from marijuana (cannabis) and hemp.
[0183] In some examples, in lieu of the isolate, a plant extract is used instead. Example 1
Method of making delta 8 tetrahydrocannabinol ( D8 THC) delta 10 tetrahydrocannabinol ( D10 THC) and/or cannabinol (CBN)
[0184] 1. An extract is obtained that comprises at least one of delta 9 tetrahydrocannabinol ( D9 THC) or a cannabidiol (CBD).
[0185] 2. The extract is heated to at least 70 degrees centigrade to make a heated extract.
[0186] 3. At least 0.0005:1 weight to weight of iodine to CBD is added to the heated extract.
[0187] 4. The heated extract is for at least 20 minutes while stirring, such that the ( D9 THC or CBD is converted into D8 THC, delta 10 tetrahydrocannabinol ( D10 THC) and/or cannabinol (CBN). Example 2
Method of making D8 THC, D8 THC and/or CBN
[0188] 1. An extract is obtained that comprises at least one of D9 THC or a CBD;
[0189] 2. The extract is heated to at least 70 degrees centigrade to make a heated extract.
[0190] 3. A catalyst is added to the heated extract or composition, wherein the extract or composition to catalyst is present in a ratio of about 1 : 0.0005 (grams of extract or composition to grams of catalyst) to about 1:1 (grams of extract or composition to grams of catalyst).
[0191] 4. The extract is heated for an additional at least 20 minutes while stirring, such that the D9 THC or CBD is converted into D8 THC, D10 THC and/or CBN. Example 3
Method of making D8 THC and/or CBN (and/or homologs thereof)
[0192] 1. An isolate is obtained that comprises at least a CBD (or a homolog thereof).
[0193] 2. The isolate is heated to between 55 and 800 degrees centigrade to make a heated isolate;
[0194] 3. Between: 0.0001:1 (w/w) of a halogen or a free radical generator to CBD (or a homolog thereof) to 10:1 (w/w) of halogen or a free radical generator to CBD (or a homolog thereof) is added to the heated isolate.
[0195] 4. The isolate is heated for an additional at least 30 minutes, such that the CBD (or a homolog thereof) is converted into D8 THC and/or CBN (Cannabinol) (or a homolog thereof). Example 4
Method of making D8 THC and/or CBN or a homolog thereof
[0196] 1. An isolate is obtained that comprises a CBD or a homolog thereof.
[0197] 2. The isolate is heated to at least 55 degrees centigrade to make a heated isolate.
[0198] 3. A free radical generator is added to the heated isolate, wherein the isolate to free radical generator is present in a ratio of about 1:0.0001 (grams of isolate to grams of free radical generator) to about 1:10 (grams of isolate to grams of free radical generator).
[0199] 4. the isolate is heated for an additional at least 20 minutes while stirring, such that the CBD or homolog thereof is converted into D8 THC (or a homolog thereof) and/or CBN (or a homolog thereof).
Example 5
[0200] Each one of Examples 1-4 can be employed for the reaction scheme noted above in the alternative. This allows for the conversion of a CBD homolog to one or both of a CBN homolog and/or a THC homolog (as shown in FIG.1).
[0201] While various embodiments are provided herein in terms of an isolate, in some embodiments, any one of these embodiments can be modified and applied to an extract.
[0202] Although the present application has been described in detail above, it will be understood by one of ordinary skill in the art that various modifications can be made without departing from the spirit of the invention. Accordingly, the present application is limited only by the following claims. All cited patents, patent applications and publications referred to in this application are herein incorporated by reference in their entirety. In this application, the use of the singular can include the plural unless specifically stated otherwise or unless, as will be understood by one of skill in the art in light of the present disclosure, the singular is the only functional embodiment. Thus, for example, "a" can mean more than one, and "one embodiment" can mean that the description applies to multiple embodiments. Additionally, in this application, "and/or" denotes that both the inclusive meaning of "and" and, alternatively, the exclusive meaning of "or" applies to the list. Thus, the listing should be read to include all possible combinations of the items of the list and to also include each item, exclusively, from the other items. The addition of this term is not meant to denote any particular meaning to the use of the terms "and" or "or" alone. The meaning of such terms will be evident to one of skill in the art upon reading the particular disclosure. All references cited herein, including patents, patent applications, papers, text books, and the like, and the references cited therein, to the extent that they are not already, are hereby incorporated by reference in their entirety. In the event that one or more of the incorporated literature and similar materials differs from or contradicts this application, including but not limited to defined terms, term usage, described techniques, or the like, this application controls. The foregoing description details certain preferred embodiments of the invention and describes the best mode contemplated by the inventors. It will be appreciated, however, that no matter how detailed the foregoing may appear in text, the invention may be practiced in many ways and the invention should be construed in accordance with the appended claims and any equivalents thereof. As will be appreciated by one of skill in the art, while the present specification may simply use one of the terms "comprise," "consists," or "consists essentially of," this is simply a shorthand way of describing all three possibilities, unless otherwise specified or unless the term is used in the claim (in which case the terms will have their
normally accepted meanings under claim interpretation). Thus, as the terms are used above, they designate all three possibilities, unless explicitly noted otherwise.
Claims
1. A method of making delta 8 tetrahydrocannabinol ( D8 THC), delta 10 tetrahydrocannabinol ( D10 THC) and/or cannabinol (CBN), the method comprising:
a) providing an extract or composition that comprises at least one of delta 9 tetrahydrocannabinol ( D9 THC) or a cannabidiol (CBD);
b) heating the extract or composition to at least 70 degrees centigrade to make a heated extract;
c) adding at least 0.0005:1 weight to weight of iodine to CBD to the heated extract or composition; and
d) continue heating for at least 20 minutes while stirring, such that the ( D9 THC or CBD is converted into D8 THC, delta 10 tetrahydrocannabinol ( D10 THC) and/or cannabinol (CBN).
2. The method of claim 1, wherein the extract or composition comprises CBD.
3. The method of claim 2, wherein the CBD is converted to D8 THC.
4. The method of any one of claims 1-3, wherein there is no significant amount of D9 THC in the product containing D8 THC.
5. The method of any one of claims 1-3, wherein less than 0.3% w/w of D9 THC is present after the reaction.
6. The method of claim 1, wherein at least 50% of the CBD is converted to D8 THC.
7. The method of claim 2, wherein at least 99% of the CBD is converted to D8 THC.
8. The method of any one of claims 1-7, wherein at least 90% of the CBD is converted to D8 THC.
9. The method of any one of claims 1-8, wherein substantially all CBD is converted to D8 THC.
10. The method of any one of claims 1-9, wherein the extract or composition is heated to at least 55 degrees centigrade.
11. The method of any one of claims 1-10, wherein at least 1.0 g of iodine is employed.
12. The method of any one of claims 1-10, wherein a ratio of 0.001:1 w/w of iodine to CBD is used.
13. The method of any one of claims 1-12, further comprising the addition of calcium carbonate to the heated extract or composition.
14. The method of any one of claims 1-13, further comprising the addition of sodium thiosulphate.
15. The method of any one of claims 1-14, wherein the extract or composition is prepared by CO2 extraction.
16. The method of any one of claims 1-15, wherein a ratio of 40 g of extract or composition is employed to 1.2g of elemental iodine.
17. The method of any one of claims 1-16, wherein the extract or composition is first heated to at least 55 degrees centigrade for 20 minutes while stirring and then heated to at least 55 centigrade for at least 20 minutes.
18. The method of any one of claims 1-17, wherein the extract or composition is first heated to 90 degrees centigrade.
19. The method of any one of claims 1-18, wherein the method comprises stirring and heating to at least 100 degrees centigrade.
20. The method of any one of claims 1-19, wherein the process does not comprise the addition of a solvent.
21. The method of any one of claims 1-19, wherein the process does not involve a use of a solvent between providing a extract or composition and production of D8 THC.
22. The method of any one of claims 1-21, wherein no organic solvent is employed during a heating step b).
23. The method of any one of claims 1-21, wherein no organic solvent is employed during d).
24. The method of any one of claims 1-21, wherein no organic solvent is employed during a, b, c, or d.
25. The method of any one of claims 1-24, wherein no organic solvent is employed during the process.
26. The method of any one of claims 1-25, wherein the extract or composition is CO2 extracted from hemp.
27. The method of any one of claims 1-26, wherein the extract or composition is decarboxylated.
28. The method of any one of claims 1-25, wherein the extract or composition is CO2 extracted from hemp and the extract or composition is then decarboxlated in order to produce the extract or composition used as the starting material.
29. A method of making D8 THC, the method comprising:
a) providing an extract or composition that comprises at least one of D9 THC or a CBD (or homologs of either);
b) heating the extract or composition to at least 70 degrees centigrade to make a heated extract;
c) adding a catalyst to the heated extract or composition, wherein the extract or composition to catalyst is present in a ratio of about 1 : 0.0005 (grams of extract or composition to grams of catalyst) to about 1:1 (grams of extract or composition to grams of catalyst); and
d) continue heating for at least 20 minutes while stirring, such that the D9 THC or CBD (or homologs of either) is converted into D8 THC, D10 THC and/or CBN (or homologs of any of these).
30. The method of claim 29, wherein the catalyst is a metallic catalyst.
31. The method of claim 29, wherein the catalyst is a non-metallic catalyst.
32. The method of any one of claims 1-20, wherein the extract is a plant extract.
33. A method of making D8 THC and/or CBN (and/or homologs thereof), the method comprising:
a) providing an isolate that comprises at least a CBD (or a homolog thereof); b) heating the isolate to between 55 and 800 degrees centigrade to make a heated isolate;
c) adding between: 0.0001:1 (w/w) of a halogen or a free radical generator to CBD (or a homolog thereof) to 10:1 (w/w) of halogen or a free radical generator to CBD (or a homolog thereof) to the heated isolate; and
d) continue heating for at least 30 minutes such that the CBD (or a homolog thereof) is converted into D8 THC and/or CBN (Cannabinol) (or a homolog thereof).
34. The method of claim 33, wherein the CBD homolog is cannabidivarin (CBDV).
35. The method of claim 34, wherein the reaction produces at least Tetrahydrocannabivarin (THCV).
36. The method of claim 33, wherein the isolate comprises between 20-95% CBD (or CBDV).
37. The method of claim 34, wherein the CBD is converted to D8 THC.
38. The method of any one of claims 33-37, wherein the halogen or a free radical generator comprises iodine.
39. The method of any one of claims 33-38, wherein there is no significant amount of D9 THC remaining.
40. The method of any one of claims 33-39, wherein less than 0.3% w/w of D9 THC is present after the reaction.
41. The method of any one of claims 33-40, wherein at least 50% of the CBD is converted to D8 THC.
42. The method of any one of claims 33-40, wherein at least 99% of the CBD is converted to D8 THC.
43. The method of any one of claims 33-42, wherein at least 90% of the CBD is converted to D8 THC.
44. The method of any one of claims 33-43, wherein substantially all CBD is converted to D8 THC and CBN.
45. The method of any one of claims 33-43, wherein substantially all CBDV is converted to D8 THCV and CBV.
46. The method of any one of claims 33-43, wherein CBDV is converted to D8 THCV and CBV.
47. The method of any one of claims 33-46, wherein the isolate is heated to at least 70 degrees centigrade.
48. The method of any one of claims 33-47, wherein at least 1.0 g of iodine is employed.
49. The method of any one of claims 33-48, wherein at least ratio of 0.001:1 w/w of iodine to CBD (or CBDV) isolate is used.
50. The method of claim 49, wherein less than a ratio of 10:1 w/w of iodine to CBD (or CBD) isolate is used.
51. The method of any one of claims 33-50, wherein the CBD isolate (or CBDV isolate) is between 20 and 99% CBD and comprises at least one of propane or butane.
52. The method of any one of claims 33-51, wherein the reaction is carried out between 1 torr and 3 million torr.
53. The method of any one of claims 33-52, further comprising the addition of sodium thiosulphate as a quencher.
54. The method of any one of claims 33-53, wherein the isolate is prepared by CO2 extraction.
55. The method of any one of claims 33-54, wherein the isolate is first heated to at least 55 degrees centigrade for 20 minutes while stirring and then heated to at least 55 centigrade for at least 20 minutes.
56. The method of any one of claims 33-50, wherein the isolate is first heated to 90 degrees centigrade.
57. The method of any one of claims 33-56, wherein the process does not comprise the addition of a solvent.
58. The method of any one of claims 33-56, wherein the process is performed in a solvent.
59. The method of any one of claims 33-58, wherein the isolate is decarboxylated.
60. A method of making D8 THC and/or CBN or a homolog thereof, the method comprising:
a) providing an isolate that comprises a CBD or a homolog thereof;
b) heating the isolate to at least 55 degrees centigrade to make a heated isolate;
c) adding a free radical generator to the heated isolate, wherein the isolate to free radical generator is present in a ratio of about 1:0.0001 (grams of isolate to grams of free radical generator) to about 1:10 (grams of isolate to grams of free radical generator); and
d) continue heating for at least 20 minutes while stirring, such that the CBD or homolog thereof is converted into D8 THC (or a homolog thereof) and/or CBN (or a homolog thereof).
61. The method of any one of claims 33-60, wherein the isolate is from a plant.
62. The method of any one of claims 33-60, wherein, in lieu of the isolate, a plant extract is used instead.
63. A method of converting A to C, D, or C and D as denoted below:
wherein, R1 and R2 can be any alkyl group.
64. The method of claim 63, wherein R1 and R2 are separately selected from any alkyl that is 1-20 carbon atoms in length.
65. The method of claim 64, further comprising
a) providing an isolate that comprises the compound A (a CBD homolog);
b) heating the isolate to between 55 and 800 degrees centigrade to make a heated isolate;
c) adding between: 0.0001:1 (w/w) of a halogen or a free radical generator to A to 10:1 (w/w) of halogen or a free radical generator to A to the heated isolate; and d) continue heating for at least 30 minutes such that the A is converted into a CBN homolog and/or a THC homolog.
66. The method of any one of claims 63-65, wherein A is a CBD homolog that is converted to one of a CBN homolog or a THC homolog.
67. The method of any one of claims 63-65, wherein A is a CBD homolog that is converted to both of a CBN homolog and a THC homolog.
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962860986P | 2019-06-13 | 2019-06-13 | |
| US62/860,986 | 2019-06-13 | ||
| US201962869698P | 2019-07-02 | 2019-07-02 | |
| US62/869,698 | 2019-07-02 | ||
| US201962871427P | 2019-07-08 | 2019-07-08 | |
| US62/871,427 | 2019-07-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2020252277A1 true WO2020252277A1 (en) | 2020-12-17 |
Family
ID=73781875
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2020/037456 Ceased WO2020252277A1 (en) | 2019-06-13 | 2020-06-12 | Making delta 8 thc, delta 10 thc and/or cannabinol from cbd |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2020252277A1 (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021139740A1 (en) | 2020-01-08 | 2021-07-15 | 成都百裕制药股份有限公司 | Tetrahydrocannabinol derivative, and preparation method therefor and medical use thereof |
| US12281091B1 (en) | 2024-01-03 | 2025-04-22 | Florascience Inc. | Methods of preparing cannabinoids or derivatives thereof |
| WO2025147239A1 (en) * | 2024-01-03 | 2025-07-10 | Florascience Inc. | Methods of preparing cannabinoids or derivatives thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040143126A1 (en) * | 2001-03-07 | 2004-07-22 | Webster G. R. Barrie | Conversion of cbd to delta8-thc and delta9-thc |
| US20100210860A1 (en) * | 2005-06-22 | 2010-08-19 | Bionorica Ag | Method for the preparation of dronabinol |
| US20170008868A1 (en) * | 2015-07-10 | 2017-01-12 | Noramco, Inc. | Process for the production of cannabidiol and delta-9-tetrahydrocannabinol |
-
2020
- 2020-06-12 WO PCT/US2020/037456 patent/WO2020252277A1/en not_active Ceased
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040143126A1 (en) * | 2001-03-07 | 2004-07-22 | Webster G. R. Barrie | Conversion of cbd to delta8-thc and delta9-thc |
| US20100210860A1 (en) * | 2005-06-22 | 2010-08-19 | Bionorica Ag | Method for the preparation of dronabinol |
| US20170008868A1 (en) * | 2015-07-10 | 2017-01-12 | Noramco, Inc. | Process for the production of cannabidiol and delta-9-tetrahydrocannabinol |
Non-Patent Citations (1)
| Title |
|---|
| POLLASTRO F. ET AL: "Iodine-Promoted Aromatization of p-Menthane-Type Phytocannabinoids", J. NAT. PROD., vol. 81, 14 December 2017 (2017-12-14), pages 630 - 633, XP055730801, DOI: 10.1021/acs.jnatprod.7b00946 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021139740A1 (en) | 2020-01-08 | 2021-07-15 | 成都百裕制药股份有限公司 | Tetrahydrocannabinol derivative, and preparation method therefor and medical use thereof |
| US12281091B1 (en) | 2024-01-03 | 2025-04-22 | Florascience Inc. | Methods of preparing cannabinoids or derivatives thereof |
| WO2025147239A1 (en) * | 2024-01-03 | 2025-07-10 | Florascience Inc. | Methods of preparing cannabinoids or derivatives thereof |
| US12371412B2 (en) | 2024-01-03 | 2025-07-29 | Florascience Inc. | Methods of preparing cannabinoids or derivatives thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2020252277A1 (en) | Making delta 8 thc, delta 10 thc and/or cannabinol from cbd | |
| Araujo et al. | Enhanced extraction of spent coffee grounds oil using high-pressure CO2 plus ethanol solvents | |
| EA026417B1 (en) | Process for the production of alpha-tocotrienol and derivatives thereof | |
| HU227796B1 (en) | Method for producing an extract from cannabis plant matter, containing a tetrahydrocannabinol and a cannabidiol and cannabis extracts | |
| Vitasari et al. | Glycolaldehyde co-extraction during the reactive extraction of acetic acid with tri-n-octylamine/2-ethyl-1-hexanol from a wood-based pyrolysis oil-derived aqueous phase | |
| HUE027294T2 (en) | Method for Fractionation of Knotted Wood Extract and Use of Liquid-Liquid Extraction to Clean Knotted Wood Extract | |
| TW201623229A (en) | New process for the preparation of high purity prostaglandins | |
| CN1951888A (en) | Process for purifying solanesol from tobacco leaf extract | |
| US10934238B2 (en) | Organic solubilisation and/or extraction solvent, extraction method using said solvent, and extracts obtained by said method | |
| del Valle et al. | Supercritical CO2 extraction of solids using aqueous ethanol as static modifier is a two-step mass transfer process | |
| EP4244201A1 (en) | Production of cannabidiol from hemp using subcritical liquid carbon dioxide | |
| US7119238B2 (en) | Process for purification and crystallization of palm oil carotenoids | |
| EP4017846A1 (en) | Methods for converting thc-rich cannabinoid mixtures into cbn-rich cannabinoid mixtures | |
| CN100357358C (en) | Preparation method of lycopene | |
| JP2016023174A (en) | Functional agent having Maillard reaction inhibitory function or antioxidant function | |
| FR2980791A1 (en) | PROCESS FOR THE PREPARATION OF A MIXTURE OF ALCOHOLS | |
| CN1098903A (en) | 6,6-dimethyl-2-fatty acyl group hexamethylene-4-alkene-1, the derivant of 3-diketone | |
| EP2542520B1 (en) | Method for obtaining biosolvent compositions by esterification and resulting biosolvent compositions | |
| CN104628546A (en) | 4-hydroxyl-3-(1, 2-dimethyl-2-propylene) benzaldehyde and use | |
| WO2021035344A1 (en) | Methods for reducing thc content in complex cannabinoid mixtures in which thc is a minor component | |
| EP3555057B1 (en) | Process for the preparation of tocols and squalene | |
| US11926606B1 (en) | Isolation of tocopherol from Commiphora myrrha | |
| US6384246B1 (en) | Process for the preparation of maltol from plants belonging to the genus Abies | |
| CN117337188A (en) | Method for producing galangal extract containing 1’-acetoxypiperol acetate | |
| CN112409301A (en) | Extraction process of paclitaxel extract and paclitaxel composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 20823463 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 20823463 Country of ref document: EP Kind code of ref document: A1 |